Senior Editor, Diagnostic Imaging
In a newly updated guidance, the American Cancer Society recommends the expansion of annual lung cancer screening with low-dose computed tomography (LDCT) for current or previous smokers 50 to 80 years of age who have a 20-pack-year or greater history of smoking.
Featuring 12 prior FDA clearances for chest X-ray and non-contrast head CT, the Annalise Triage platform may help streamline radiology workflows and prioritize timely diagnosis of urgent conditions.
The Current Procedural Terminology (CPT) Category III code for the Unfold AI prostate cancer mapping platform can be utilized by radiologists starting in July 2024.
In a recent video interview series, Dushyant Sahani, M.D., discussed the critical role of contrast media in diagnostic imaging, lessons learned from the contrast media shortage, key considerations with generic agents and currently unmet needs with contrast agents.
The executive order seeks to promote continued innovation and growth with artificial intelligence (AI) while ensuring monitoring of AI models for safety, privacy, and equity.
The expanded 510(k) clearance from the FDA for the Optimizer Smart Mini system allows full-body MRI use for patients with heart failure who are receiving cardiac contractility modulation (CCM).
New research shows that pelvic MRI offers equivalent sensitivity but nearly 20 percent greater specificity than transvaginal ultrasound for the classification of adnexal lesions.
In a study of over 375,000 people, researchers found that a high liver MRI proton density fat fraction was associated with an over 7.5-fold higher risk for non-alcoholic steatohepatitis, a 4.5-fold higher risk for malignancy, and a 3.8-fold elevated risk for cirrhosis of the liver.
The update of the S-scan magnetic resonance imaging (MRI) system reportedly offers an improved ergonomic design, algorithms to enhance image quality and reduced scan times.
A 49-study meta-analysis revealed that MRI-based and CT-based radiomics models outperformed clinical models for predicting recurrence of hepatocellular carcinoma.
An emerging deep learning algorithm can reportedly triage 40 percent of no-change X-rays while providing 88 to 90 percent accuracy for detecting changes with X-rays obtained in the emergency department and intensive care unit at a tertiary referral hospital, according to recently published research.
Emerging research findings suggest that a longer prostatic urethral length on MRI is associated with a 70 percent increased risk of grade >2 acute urinary toxicity after radiotherapy for prostate cancer.
The artificial intelligence (AI)-powered software VUNO Med-DeepBrain reportedly automates brain MRI segmentation and provides access to volumetric data on over 100 regions of the brain.
While ChatGPT has the potential to help streamline responses to imaging-related questions from patients, the authors of a new study found that a third of ChatGPT responses to unprompted questions on medical imaging were not “fully relevant.”
In a newly published literature review, researchers examined the benefits of diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) for breast cancer characterization and monitoring of neoadjuvant chemotherapy, current drawbacks that thwart wider adoption, and emerging techniques that may enhance the modality’s effectiveness.
In a multicenter cohort of patients with interstitial lung disease (ILD), a deep learning classification tool demonstrated an 81 percent sensitivity rate and a 77 percent specificity rate for predicting usual interstitial pneumonia on computed tomography (CT) scans.
Artificial intelligence (AI) software assigned high malignancy risk scores to mammography exams completed up to two years prior to breast cancer diagnosis in over 38 percent of screen-detected cancer cases and over 39 percent of interval cancer cases, according to newly published research.
The Allia IGS Pulse reportedly has the first monopolar X-ray tube geared to interventional procedures.
Utilized in conjunction with screening digital mammography or digital breast tomosynthesis (DBT), the artificial intelligence (AI)-powered software cmAngio may help detect and localize breast arterial calcification (BAC), an incidental finding that has been linked to an elevated risk for heart disease and stroke.
Various organizations have applauded the decision by the CMS to remove National Coverage Determination (NCD) limitations to coverage for amyloid PET scans, including the limitation of Medicare or Medicaid coverage to one PET scan per a patient’s lifetime. It remains to be seen, however, how coverage decisions will be made by local Medicare Administrative Contractors (MACs).
Offering dedicated computed tomography (CT) assessment of the cardiovascular system, the SpotLight and SpotLight Duo systems reportedly provide high-resolution imaging for diagnosis and monitoring of cardiovascular diseases.
Combining phased and linear arrays on a single head, the Clarius PAL HD3 ultrasound device was unveiled at the recent American College of Emergency Physicians (ACEP) Scientific Assembly conference.
In a study of 355 multiparametric prostate MRI exams from a total of 71 scanners from 41 facilities in 18 countries, researchers found that only 23 scanners achieved a PI-QUAL score of 5 for optimal image quality.
In a study of over 25,000 Medicare beneficiaries with mild cognitive decline or dementia, researchers found that obtaining amyloid positron emission tomography (PET) scans resulted in no statistically significant differences upon subsequent hospitalization and emergency department visit rates at one year.
In a recently published literature review, researchers examined the potential impact of advanced sequences, scanners, patient preparation and AI on image quality for prostate MRI exams.
By leveraging subtle signals on routine X-rays to assess bone mineral density (BMD), the technology may facilitate earlier detection of osteoporosis and help prevent fragility fractures.
In reportedly the eighth FDA 510(k) clearance for Hyperfine’s Swoop portable brain MRI device, clinicians will now have access to enhanced denoising capabilities with diffusion-weighted imaging (DWI) sequences.
In a recent video interview, Ashesh Jani, M.D., discussed a subset analysis from the SPOTLIGHT trial that examined the utility of the PET PSMA agent flotufolastat F 18 (Posluma) for detecting prostate cancer recurrence in men with low PSA levels lower than 1 ng/mL.
Geared to clinicians who may lack ultrasound expertise, the artificial intelligence (AI)-powered Caption Guidance technology reportedly provides stepwise instruction for acquiring optimal cardiac ultrasound images.
In a study of over 500 people with carpal tunnel syndrome, researchers found that 57 percent returned to work three days after being treated with UltraGuideCTR, a modality which enables real-time ultrasound guidance for carpal tunnel release.
